Strata Critical Medical, Inc.
SRTA
$6.03
$0.091.52%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 7.60% | 0.89% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 7.60% | 0.89% | |||
| Cost of Revenue | 7.55% | -3.36% | |||
| Gross Profit | 7.78% | 20.97% | |||
| SG&A Expenses | -9.38% | 3.93% | |||
| Depreciation & Amortization | 345.96% | -42.93% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 11.26% | -1.51% | |||
| Operating Income | -140.63% | 46.58% | |||
| Income Before Tax | -537.80% | 144.58% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -537.80% | 144.58% | |||
| Earnings from Discontinued Operations | -- | 92.80% | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -588.21% | 124.39% | |||
| EBIT | -140.63% | 46.58% | |||
| EBITDA | 240.35% | 306.99% | |||
| EPS Basic | -584.13% | 124.16% | |||
| Normalized Basic EPS | -15,250.00% | 101.79% | |||
| EPS Diluted | -584.13% | 124.16% | |||
| Normalized Diluted EPS | -15,250.00% | 101.79% | |||
| Average Basic Shares Outstanding | 1.04% | 0.74% | |||
| Average Diluted Shares Outstanding | -4.39% | 6.46% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||